Patient Engagement Solutions MarketSize, Share & Industry Analysis, 2026-2034By Delivery TypeBy ComponentBy FunctionalityBy Therapeutic AreaBy ApplicationBy End-user

Patient engagement solutions are software platforms and connected devices that let a health system, hospital or insurer communicate with, educate and monitor patients outside a clinical visit, spanning secure messaging, remote health tracking, appointment and billing tools bundled as web or cloud-hosted portals, mobile apps or on-premise systems tied into a provider's records. Buyers are hospitals, physician groups, health insurers and government payer programs seeking to keep patients following a care plan between visits, plus the technology vendors and system integrators that build and support these platforms for them.

The global patient engagement solutions market is valued at USD 30.5 billion in 2025 and is set to reach USD 92.5 billion by 2034, a compound annual growth rate of 13.08% across the 2026-2034 forecast period. The study tracks the market across USD 17.3 billion in 2020, USD 27.3 billion in 2024, USD 34.6 billion in 2026 and USD 58.3 billion in 2030.

30% of 2025 revenue sits in Communication, worth USD 9.15 billion and rising to USD 24.975 billion at 27% by 2034, the largest functionality line in both years. Growth is fastest in Patient Education at 15.61% and slowest in Administrative at 11.14%. The lines gaining share are Health Tracking & Insights and Patient Education. Communication, Billing & Payments, Administrative and Others lose share without losing revenue.

By delivery type, Web & Cloud-based accounts for 68% of 2025 revenue at USD 20.74 billion, reaching USD 72.15 billion and 78% by 2034. It is also the fastest-growing line on this axis at 14.86%, so the split concentrates over the period instead of balancing. This axis divides the same revenue as the functionality split instead of adding to it, so the two are read together and never summed.

Geographically, 42% of 2025 revenue sits in North America (USD 12.81 billion rising to USD 34.23 billion) ahead of Asia Pacific at 24% and USD 7.32 billion. Middle East and Africa is smallest, at 6%. Because Asia Pacific and Latin America take share, the revenue added by 2034 concentrates instead of spreading across all five regions.

Behind these figures sit five regions, six functionality lines and six segmentation axes, each reported for every year from 2020 to 2034. The headline 2025 value is a triangulation of published figures and category proxies, short of a directly sourced total, and the same applies to the segment, regional and country breakdowns drawn from it.

• The global patient engagement solutions market moves from USD 17.3 billion in 2020 to USD 30.5 billion in 2025 and USD 92.5 billion by 2034, the forecast period compounding at 13.08% a year.
• 30% of 2025 revenue sits in Communication (USD 9.15 billion) and it remains the largest functionality line in 2034 at USD 24.975 billion and 27%.
• Fastest growth on the functionality axis belongs to Patient Education: 15.61% a year, USD 2.745 billion to USD 10.175 billion, and a share moving from 9% to 11%.
• Scenario range for 2034 runs from USD 83.25 billion in the bear case to USD 101.75 billion in the bull case, against a base-case USD 92.5 billion, the spread a plan built on this forecast has to absorb.
• 42% of 2025 revenue is generated in North America, worth USD 12.81 billion and rising to USD 34.23 billion by 2034; Middle East and Africa is smallest at 6%.
• 85% of North America's base-year revenue comes from the United States alone: USD 10.89 billion in 2025, rising to USD 29.09 billion by 2034, which is why it is that region's worked example.
• Fifteen years are reported, 2020 to 2034 with 2025 as the base: revenue, share and growth rate per line, per axis and per region, not as a single blended series.

Three movements define the forecast period in the global patient engagement solutions market: how the functionality mix changes, where regional weight shifts, and the rate at which the total compounds.

All three are changes in mix, not in direction: nothing contracts, and the movement is in which lines and regions absorb the new revenue.

Composition shifts on the functionality axis. 15.61% against 11.14%: that gap, between Patient Education and Administrative, is the largest on the functionality axis. By 2034 the two sit at 11% and 12% of revenue, against 9% and 14% in 2025. Neither contracts: USD 2.745 billion becomes USD 10.175 billion, USD 4.27 billion becomes USD 11.1 billion. What the spread decides is which of them a supplier's revenue is exposed to.

The regional balance moves. Asia Pacific moves from 24% of revenue in 2025 to 29% in 2034, worth USD 7.32 billion rising to USD 26.83 billion; Latin America moves from 7% of revenue in 2025 to 8% in 2034, worth USD 2.14 billion rising to USD 7.4 billion. The remaining regions grow in absolute terms while giving up share: North America at 42% moving to 37%, Europe at 21% moving to 20%, Middle East and Africa at 6% moving to 6%. Revenue added in this market is therefore concentrating geographically instead of spreading evenly, and a participant weighted toward a share-losing region grows more slowly than the market even while its own revenue climbs.

A continuation, not an inflection. Reading the series: USD 17.3 billion in 2020, USD 27.3 billion in 2024, USD 30.5 billion in 2025, USD 34.6 billion in 2026, USD 58.3 billion in 2030 and USD 92.5 billion in 2034. Against 12.01% through the historical period, the 13.08% forecast rate is a continuation; no year in the series interrupts it. The risk in the number sits in the mix assumptions, not in whether the market grows at all, which is where the functionality and regional sections come in.

Growth is concentrated in Patient Education

The 13.08% forecast rate rests on three things that can be measured separately: the size of the existing base, the mix shift on the functionality axis, and where regional growth is concentrated.

Downside case: USD 83.25 billion by 2034, against USD 92.5 billion in the base case

Where the forecast could be beaten

One functionality line carries the market

In North America, 42% of global revenue puts 2025 at USD 12.81 billion and reaches USD 34.23 billion by 2034. By revenue it sits first across the study, and the ranking does not change between 2025 and 2034.

By 2034 the share stands at 37%, a shift in share, not in direction: revenue climbs every year while the market's centre of gravity moves elsewhere.

Communication leads here as it does globally, at 30% of 2025 revenue, and Patient Education again grows fastest at 15.61%. North America is reported axis by axis and country by country in the full study.

USD 10.89 billion of North America's 2025 revenue is generated in the United States, the region's largest market, reaching USD 29.09 billion by 2034. Carrying 85% of the region in the base year, it sets North America's direction instead of merely contributing to it. Set against USD 12.81 billion and USD 34.23 billion for the region, it is why this market, and not a smaller one, is the one reported in full.

The functionality pattern in the United States is the global one: 30% of 2025 revenue in Communication, 27% by 2034, against 15.61% growth in Patient Education taking it from 9% to 11%. Because the country carries 85% of North America, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Per-functionality revenue for the United States appears on its own in the full report.

The Food and Drug Administration regulates this category only insofar as a platform performs diagnostic or treatment functions; most patient engagement tools, covering scheduling, secure messaging, and portal access to records, fall outside the agency's device definition thanks to the clinical decision support carve-out established in federal cures legislation. Where that carve-out does not apply, a supplier must pursue premarket clearance and maintain quality system compliance. Because these platforms handle protected health information, HIPAA governs privacy and security obligations, requiring administrative, physical, and technical safeguards along with signed business associate agreements. The Office of the National Coordinator's interoperability and information blocking rules further constrain how patient data must be made accessible through certified application programming interfaces.

The suppliers tracked in this study (Allscripts Healthcare, LLC, Orion Health, Cerner Corporation, McKesson Corporation, athenahealth, Inc., IBM, Medecision, GetWellNetwork, Inc., MEDHOST, Lincor, IQVIA, Wolters Kluwer N.V., Force Therapeutics LLC, Quil, Greenway Health, LLC, Mytonomy, Klara Technologies, Inc., Solutionreach, Inc., CureMD Healthcare, Patient point LLC, Vivify Health and Nuance Communications, Inc.) compete in the United States across the functionality lines above. Volume sits in Communication at 30% of 2025 revenue; movement sits in Patient Education at 15.61% growth. Country-level shares and positioning per company sit in the full report.

Canada is sized at USD 1.92 billion in 2025, rising to USD 5.13 billion by 2034; 6.3% of global revenue and 15% of North America. It is reported separately from the United States across every segmentation axis in the full report.

21% of the global patient engagement solutions market sits in Europe in 2025, worth USD 6.41 billion and reaches USD 18.5 billion by 2034. That makes it the third-largest region covered, in 2025 and again in 2034.

20% of global revenue sits here in 2034, below the 2025 level, though revenue still rises throughout; the shift is in the region's weight against faster-growing ones, which is not the same as weakening demand.

The functionality mix reported at global level applies here, with Communication the largest line at 30% of 2025 revenue and Patient Education the fastest-growing at 15.61%. Revenue for Europe is broken out by every segmentation axis and by country in the full report.

Germany is the largest market within Europe, generating USD 1.92 billion in 2025 and projected to reach USD 5.55 billion by 2034. It accounts for 30% of regional revenue in the base year, the largest single share without dominating the region outright. Against regional totals of USD 6.41 billion in 2025 and USD 18.5 billion in 2034, it is the country the full report breaks out in detail.

Germany buys along the same lines as the market globally; Communication first at 30% of 2025 revenue and 27% in 2034, Patient Education fastest at 15.61% on a share moving from 9% to 11%. Because the country carries 30% of Europe, a movement in its own mix shows up in the regional totals instead of being averaged away by neighbouring markets. Per-functionality revenue for Germany appears on its own in the full report.

Patient engagement software is treated as a medical device under the EU Medical Device Regulation only when it performs a diagnostic or therapeutic function; the country's device authority, BfArM, oversees that pathway alongside the notified body conformity assessment it requires. Most patient portals and communication tools instead fall under Germany's digital health application framework, also administered by BfArM, which requires a manufacturer to demonstrate positive care effects and meet data protection and interoperability criteria before a listing is granted. Data handling throughout must conform to the General Data Protection Regulation and Germany's federal data protection act, with particular attention to consent management and restrictions on transferring patient data outside the European Economic Area.

Allscripts Healthcare, LLC, Orion Health, Cerner Corporation, McKesson Corporation, athenahealth, Inc., IBM, Medecision, GetWellNetwork, Inc., MEDHOST, Lincor, IQVIA, Wolters Kluwer N.V., Force Therapeutics LLC, Quil, Greenway Health, LLC, Mytonomy, Klara Technologies, Inc., Solutionreach, Inc., CureMD Healthcare, Patient point LLC, Vivify Health and Nuance Communications, Inc. are the suppliers covered in Germany. Volume sits in Communication at 30% of 2025 revenue; movement sits in Patient Education at 15.61% growth. That makes Europe a 21% share of 2025 global revenue, USD 6.41 billion rising to USD 18.5 billion, for any supplier deciding where to concentrate.

5.48% of global revenue is generated in the United Kingdom; USD 1.67 billion in 2025, reaching USD 4.81 billion in 2034, and 26% of Europe.

Within Europe, France accounts for 18% of regional revenue and 3.77% of the global total, worth USD 1.15 billion in 2025 and USD 3.33 billion by 2034.

USD 7.32 billion of 2025 revenue is generated in Asia Pacific, 24% of the global patient engagement solutions market and reaches USD 26.83 billion by 2034. It is a leading region on this axis, second by revenue throughout the period.

Share climbs to 29% by 2034, on growth above the market's own 13.08%, and with a bigger contribution to the revenue added over the period than the base-year figure suggests.

Segment composition follows the global pattern: Communication largest at 30% of 2025 revenue, Patient Education fastest at 15.61%. Per-axis and per-country detail for Asia Pacific sits in the full report.

The largest single market in Asia Pacific is China, at USD 2.49 billion in 2025 and USD 9.12 billion in 2034. At 34% of the region in 2025 it leads, but a majority of Asia Pacific's revenue is generated in other markets. The region itself runs USD 7.32 billion to USD 26.83 billion over the same period, and this is the market carrying the country-level detail in the full report.

Demand in China follows the functionality mix reported at global level: Communication is the largest line at 30% of 2025 revenue, moving to 27% by 2034, while Patient Education grows fastest at 15.61% and takes its share from 9% to 11%. Since 34% of Asia Pacific's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. Per-functionality revenue for China appears on its own in the full report.

Software that performs diagnostic or treatment functions is regulated as medical device software by the National Medical Products Administration, which requires classification review and registration before a product may be marketed for clinical use. Patient engagement platforms limited to scheduling, communication, and general health information typically sit outside that device definition, though they remain subject to China's cybersecurity and personal information protection statutes, which require data localization, security assessments for cross-border transfer, and explicit user consent for handling health data. A supplier operating in this space must also observe sector guidance from health authorities on the classification and grading of medical information systems.

Competition in China runs between the suppliers this study tracks: Allscripts Healthcare, LLC, Orion Health, Cerner Corporation, McKesson Corporation, athenahealth, Inc., IBM, Medecision, GetWellNetwork, Inc., MEDHOST, Lincor, IQVIA, Wolters Kluwer N.V., Force Therapeutics LLC, Quil, Greenway Health, LLC, Mytonomy, Klara Technologies, Inc., Solutionreach, Inc., CureMD Healthcare, Patient point LLC, Vivify Health and Nuance Communications, Inc.. Communication, at 30% of 2025 revenue, is where the volume sits, and Patient Education, growing at 15.61%, is where position changes hands over the forecast period. The commercial size of that position is USD 7.32 billion in 2025 and USD 26.83 billion by 2034, 24% of the global total in the base year.

5.28% of global revenue is generated in Japan; USD 1.61 billion in 2025, reaching USD 5.9 billion in 2034, and 22% of Asia Pacific.

Within Asia Pacific, India accounts for 16% of regional revenue and 3.84% of the global total, worth USD 1.17 billion in 2025 and USD 4.29 billion by 2034.

Latin America holds 7% of the global patient engagement solutions market in 2025, worth USD 2.14 billion rising to USD 7.4 billion in 2034. It is a marginal region on this axis, fourth by revenue throughout the period.

Share climbs to 8% by 2034, on growth above the market's own 13.08%, and with a bigger contribution to the revenue added over the period than the base-year figure suggests.

Segment composition follows the global pattern: Communication largest at 30% of 2025 revenue, Patient Education fastest at 15.61%. The full report breaks Latin America out along every axis and by country.

55% of Latin America's base-year revenue comes from Brazil; USD 1.17 billion, rising to USD 4.07 billion by 2034. At 55% of the region in 2025 it leads, but a majority of Latin America's revenue is generated in other markets. Regional revenue of USD 2.14 billion in 2025 and USD 7.4 billion in 2034 sits around it, and it is the country used wherever the full report cuts a figure by geography.

Demand in Brazil follows the functionality mix reported at global level: Communication is the largest line at 30% of 2025 revenue, moving to 27% by 2034, while Patient Education grows fastest at 15.61% and takes its share from 9% to 11%. Its 55% weight in Latin America means those movements carry straight into the regional totals. Brazil carries its own functionality breakdown in the full report.

Brazil's health surveillance agency, ANVISA, regulates software as a medical device when it supports diagnosis or treatment decisions, requiring registration and adherence to the national quality and safety framework for health software before commercial release. Patient engagement tools that instead handle scheduling, messaging, and access to personal health records fall primarily under the General Data Protection Law, which sets requirements for lawful processing, consent, and security of sensitive health data. Suppliers operating within the public health system must also align with the Ministry of Health's interoperability standards for exchanging patient information across connected services.

Allscripts Healthcare, LLC, Orion Health, Cerner Corporation, McKesson Corporation, athenahealth, Inc., IBM, Medecision, GetWellNetwork, Inc., MEDHOST, Lincor, IQVIA, Wolters Kluwer N.V., Force Therapeutics LLC, Quil, Greenway Health, LLC, Mytonomy, Klara Technologies, Inc., Solutionreach, Inc., CureMD Healthcare, Patient point LLC, Vivify Health and Nuance Communications, Inc. are the suppliers covered in Brazil. Volume sits in Communication at 30% of 2025 revenue; movement sits in Patient Education at 15.61% growth. The commercial size of that position is USD 2.14 billion in 2025 and USD 7.4 billion by 2034, 7% of the global total in the base year.

2.1% of global revenue is generated in Mexico; USD 0.64 billion in 2025, reaching USD 2.22 billion in 2034, and 30% of Latin America.

In Middle East and Africa, 6% of global revenue puts 2025 at USD 1.83 billion and reaches USD 5.55 billion by 2034. It is a marginal region on this axis, fifth by revenue throughout the period.

Share settles at 6% in 2034, though revenue still rises throughout; the shift is in the region's weight against faster-growing ones, which is not the same as weakening demand.

Segment composition follows the global pattern: Communication largest at 30% of 2025 revenue, Patient Education fastest at 15.61%. Revenue for Middle East and Africa is broken out by every segmentation axis and by country in the full report.

The largest single market in Middle East and Africa is Saudi Arabia, at USD 0.55 billion in 2025 and USD 1.67 billion in 2034. 30% of the region in the base year makes it the largest market here without making it the region. Set against USD 1.83 billion and USD 5.55 billion for the region, it is why this market, and not a smaller one, is the one reported in full.

Composition here matches the global split: the largest line is Communication at 30% of 2025 revenue, easing to 27% by 2034, and the fastest is Patient Education at 15.61%, from 9% to 11%. Since 30% of Middle East and Africa's revenue is generated here, the regional numbers inherit this market's mix instead of smoothing it out. Per-functionality revenue for Saudi Arabia appears on its own in the full report.

The Saudi Food and Drug Authority regulates software that performs diagnostic or therapeutic functions as a medical device, requiring classification and registration under the kingdom's medical device framework before a product can be marketed to healthcare providers. Patient engagement platforms confined to scheduling, communication, and portal access generally sit outside that device definition, though they remain subject to the national personal data protection law, which governs consent, storage, and cross-border transfer of health information. Suppliers working with government healthcare systems must additionally align with the data governance requirements of the Saudi Data and Artificial Intelligence Authority and the health ministry's interoperability standards for connected care.

In Saudi Arabia the field is Allscripts Healthcare, LLC, Orion Health, Cerner Corporation, McKesson Corporation, athenahealth, Inc., IBM, Medecision, GetWellNetwork, Inc., MEDHOST, Lincor, IQVIA, Wolters Kluwer N.V., Force Therapeutics LLC, Quil, Greenway Health, LLC, Mytonomy, Klara Technologies, Inc., Solutionreach, Inc., CureMD Healthcare, Patient point LLC, Vivify Health and Nuance Communications, Inc.. Volume sits in Communication at 30% of 2025 revenue; movement sits in Patient Education at 15.61% growth. The commercial size of that position is USD 1.83 billion in 2025 and USD 5.55 billion by 2034, 6% of the global total in the base year.

Within Middle East and Africa, the United Arab Emirates accounts for 22% of regional revenue and 1.31% of the global total, worth USD 0.4 billion in 2025 and USD 1.22 billion by 2034.

1.08% of global revenue is generated in South Africa; USD 0.33 billion in 2025, reaching USD 1 billion in 2034, and 18% of Middle East and Africa.

Request this sample to see the full data tables and segment-level detail behind this analysis.

This report assesses the market across every segment, with revenue and a growth rate for each line in each year of the study period. It covers the drivers, trends, opportunities, restraints and challenges shaping growth, the competitive landscape and the companies profiled, and the research methodology behind every estimate. Segmentation is reported by delivery type, component, functionality, therapeutic area, application, end-user, and regional analysis covers North America, Europe, Asia Pacific, Latin America, Middle East and Africa, each broken out by country.